• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

恩格列净早期给药可改善大鼠心肝综合征中心功能。

Early administration of empagliflozin preserved heart function in cardiorenal syndrome in rat.

机构信息

Division of Nephrology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung 83301, Taiwan.

Division of Urology, Department of Surgery, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung 83301, Taiwan.

出版信息

Biomed Pharmacother. 2019 Jan;109:658-670. doi: 10.1016/j.biopha.2018.10.095. Epub 2018 Nov 4.

DOI:10.1016/j.biopha.2018.10.095
PMID:30404073
Abstract

This study tested the hypothesis that early administration of empagliflozin (Empa), an inhibitor of glucose recycling in renal tubules, could preserve heart function in cardiorenal syndrome (CRS) in rat. Chronic kidney disease (CKD) was caused by 5/6 subtotal nephrectomy and dilated cardiomyopathy (DCM) by doxorubicin (DOX) treatment. In vitro results showed that protein expressions of cleaved-caspase3 and autophagy activity at 24 h/48 h in NRK-52P cells were significantly upregulated by para-Creso treatment; these were significantly downregulated by Empa treatment. Flow cytometric analysis showed that annexin-V (i.e., early/late apoptosis) in NRK-52P cells expressed an identical pattern to cleaved-caspase3 between the two groups (all p < 0.001). Adult-male-SD rats (n = 18) were equally categorized into group 1 (sham-control), group 2 (CRS) and group 3 [CRS + Empa; 20 mg/kg/day]. By day-42 after CRS induction, left-ventricular ejection fraction (LVEF) level exhibited an opposite pattern, whereas LV end-diastolic dimension and creatinine level displayed the same pattern, to cleaved-caspase3 among the three groups (all p < 0.0001). In LV tissues, protein expressions of inflammatory (tumor-necrosis factor-α/nuclear-factor-κB/interleukin-1ß/matrix-metalloprotianse-9), oxidative stress (NOX-1/NOX-2/oxidized protein), apoptotic (mitochondrial-Bax/cleaved-caspase-3/cleaved-PARP), fibrotic (transforming-growth factor-ß/Smad3), DNA/mitochondrial-damage (γ-H2AX/cytosolic-cytochrome-C) and heart failure (brain natriuretic peptide (BNP) levels displayed an opposite pattern to LVEF among the three groups (all p < 0.0001). Additionally, cellular expressions of DNA-damage/heart-failure (γ-H2AX+//XRCC1+CD90+//BNP+) biomarkers and histopathological findings of fibrotic/condensed collagen-deposition areas and apoptotic nuclei showed an identical pattern, whereas connexin43 and small-vessel number exhibited an opposite pattern, to inflammation among the three groups (all p < 0.0001). In conclusion, Empa therapy protected heart and kidney against CRS injury.

摘要

这项研究检验了这样一个假设,即早期给予肾小管葡萄糖再循环抑制剂恩格列净(empagliflozin)可预防 5/6 肾切除和阿霉素(doxorubicin,DOX)治疗诱导的大鼠心肾综合征(cardiorenal syndrome,CRS)中的心脏功能障碍。慢性肾脏病(chronic kidney disease,CKD)由 5/6 肾切除引起,扩张型心肌病(dilated cardiomyopathy,DCM)由 DOX 治疗引起。体外结果表明,para-Creso 处理可使 NRK-52P 细胞中 caspase3 剪切和自噬活性的蛋白表达在 24 小时/48 小时显著上调;而 Empa 处理则显著下调。流式细胞术分析显示,NRK-52P 细胞中的膜联蛋白-V(即早期/晚期凋亡)与两组之间的 caspase3 表达呈相同模式(均 p<0.001)。18 只成年雄性 SD 大鼠(n=18)等分为 3 组:第 1 组(sham-control)、第 2 组(CRS)和第 3 组[CRS+Empa;20mg/kg/天]。在 CRS 诱导后第 42 天,左心室射血分数(left-ventricular ejection fraction,LVEF)水平在三组中呈现相反的模式,而左心室舒张末期内径和肌酐水平在三组中呈现相同的模式,均与 caspase3 呈正相关(均 p<0.0001)。在左心室组织中,炎症(肿瘤坏死因子-α/核因子-κB/白细胞介素-1β/基质金属蛋白酶-9)、氧化应激(NOX-1/NOX-2/氧化蛋白)、凋亡(线粒体-Bax/caspase3 剪切体/caspase-3 剪切体/cleaved-PARP)、纤维化(转化生长因子-β/Smad3)、DNA/线粒体损伤(γ-H2AX/细胞质细胞色素 C)和心力衰竭(脑钠肽(brain natriuretic peptide,BNP)水平的蛋白表达与三组中 LVEF 的变化模式相反(均 p<0.0001)。此外,细胞 DNA 损伤/心力衰竭(γ-H2AX+/+/XRCC1+/CD90+/BNP+)生物标志物的表达和纤维化/浓缩胶原沉积区和凋亡核的组织病理学发现与炎症呈相同模式,而连接蛋白 43 和小血管数量与炎症呈相反模式,与炎症呈相同模式(均 p<0.0001)。总之,Empa 治疗可预防 CRS 损伤导致的心肾损伤。

相似文献

1
Early administration of empagliflozin preserved heart function in cardiorenal syndrome in rat.恩格列净早期给药可改善大鼠心肝综合征中心功能。
Biomed Pharmacother. 2019 Jan;109:658-670. doi: 10.1016/j.biopha.2018.10.095. Epub 2018 Nov 4.
2
The cardioprotective effect of melatonin and exendin-4 treatment in a rat model of cardiorenal syndrome.褪黑素和 exendin-4 治疗在心肾综合征大鼠模型中的心脏保护作用。
J Pineal Res. 2016 Nov;61(4):438-456. doi: 10.1111/jpi.12357. Epub 2016 Sep 26.
3
Combined levosimendan and Sacubitril/Valsartan markedly protected the heart and kidney against cardiorenal syndrome in rat.联合左西孟旦和沙库巴曲缬沙坦显著保护心脏和肾脏免受大鼠心肾综合征的影响。
Biomed Pharmacother. 2022 Apr;148:112745. doi: 10.1016/j.biopha.2022.112745. Epub 2022 Feb 21.
4
SGLT2 inhibitor downregulated oxidative stress via activating AMPK pathway for cardiorenal (CR) protection in CR syndrome rodent fed with high protein diet.SGLT2 抑制剂通过激活 AMPK 通路下调氧化应激,从而在高蛋白饮食喂养的 CR 综合征啮齿动物中发挥心脏肾脏(CR)保护作用。
J Mol Histol. 2024 Oct;55(5):803-823. doi: 10.1007/s10735-024-10233-1. Epub 2024 Aug 27.
5
Entresto protected the cardiomyocytes and preserved heart function in cardiorenal syndrome rat fed with high-protein diet through regulating the oxidative stress and Mfn2-mediated mitochondrial functional integrity.恩格列净通过调节氧化应激和 Mfn2 介导的线粒体功能完整性,保护了高蛋白饮食喂养的心血肾综合征大鼠的心肌细胞并维持了心脏功能。
Biomed Pharmacother. 2021 Dec;144:112244. doi: 10.1016/j.biopha.2021.112244. Epub 2021 Oct 1.
6
The therapeutic impact of entresto on protecting against cardiorenal syndrome-associated renal damage in rats on high protein diet.恩格列净对高蛋白饮食诱导的大鼠心肝综合征相关肾损伤的治疗作用。
Biomed Pharmacother. 2019 Aug;116:108954. doi: 10.1016/j.biopha.2019.108954. Epub 2019 May 17.
7
Early Administration of Carvedilol Protected against Doxorubicin-Induced Cardiomyopathy.早期给予卡维地洛可预防阿霉素诱导的心肌病。
J Pharmacol Exp Ther. 2015 Dec;355(3):516-27. doi: 10.1124/jpet.115.225375. Epub 2015 Oct 28.
8
Combined therapy with dapagliflozin and entresto offers an additional benefit on improving the heart function in rat after ischemia-reperfusion injury.达格列净联合恩格列净治疗可改善缺血再灌注损伤后大鼠心功能。
Biomed J. 2023 Jun;46(3):100546. doi: 10.1016/j.bj.2022.06.002. Epub 2022 Jun 16.
9
Extracorporeal Shock Wave-Supported Adipose-Derived Fresh Stromal Vascular Fraction Preserved Left Ventricular (LV) Function and Inhibited LV Remodeling in Acute Myocardial Infarction in Rat.体外冲击波支持的脂肪来源新鲜基质血管成分保留左心室 (LV) 功能并抑制大鼠急性心肌梗死中的 LV 重构。
Oxid Med Cell Longev. 2018 Oct 17;2018:7518920. doi: 10.1155/2018/7518920. eCollection 2018.
10
Dapagliflozin-entresto protected kidney from renal hypertension via downregulating cell-stress signaling and upregulating SIRT1/PGC-1α/Mfn2-medicated mitochondrial homeostasis.达格列净-恩格列净可通过下调细胞应激信号和上调 SIRT1/PGC-1α/Mfn2 介导的线粒体稳态来保护肾脏免受肾性高血压的影响。
Exp Biol Med (Maywood). 2023 Dec;248(23):2421-2439. doi: 10.1177/15353702231198087. Epub 2023 Dec 7.

引用本文的文献

1
Dulaglutide markedly prevents peritoneal fibrosis in a rodent model of chronic kidney disease: Insights into the pathogenesis.度拉糖肽显著预防慢性肾病啮齿动物模型中的腹膜纤维化:对发病机制的见解。
Int J Mol Med. 2025 Oct;56(4). doi: 10.3892/ijmm.2025.5592. Epub 2025 Jul 25.
2
Potential New Applications of Sodium-Glucose Cotransporter-2 Inhibitors Across the Continuum of Cancer-Related Cardiovascular Toxicity.钠-葡萄糖协同转运蛋白2抑制剂在癌症相关心血管毒性连续过程中的潜在新应用
Pharmaceuticals (Basel). 2025 Jun 9;18(6):857. doi: 10.3390/ph18060857.
3
Doxorubicin-Induced Cardiotoxicity and the Emerging Role of SGLT2 Inhibitors: From Glycemic Control to Cardio-Oncology.
多柔比星诱导的心脏毒性以及钠-葡萄糖协同转运蛋白2抑制剂的新作用:从血糖控制到心脏肿瘤学
Pharmaceuticals (Basel). 2025 May 3;18(5):681. doi: 10.3390/ph18050681.
4
Febuxostat therapy improved the outcomes of cardiorenal syndrome rodent through alleviating xanthine oxidase-induced oxidative stress and mitochondrial dysfunction.非布司他治疗通过减轻黄嘌呤氧化酶诱导的氧化应激和线粒体功能障碍改善了心肾综合征啮齿动物的预后。
Int J Biol Sci. 2025 Feb 10;21(4):1749-1766. doi: 10.7150/ijbs.99194. eCollection 2025.
5
SGLT2 inhibitors for prevention and management of cancer treatment-related cardiovascular toxicity: a review of potential mechanisms and clinical insights.用于预防和管理癌症治疗相关心血管毒性的钠-葡萄糖协同转运蛋白2抑制剂:潜在机制与临床见解综述
Cardiooncology. 2025 Feb 11;11(1):15. doi: 10.1186/s40959-024-00284-4.
6
Cardiorenal syndrome: clinical diagnosis, molecular mechanisms and therapeutic strategies.心肾综合征:临床诊断、分子机制及治疗策略
Acta Pharmacol Sin. 2025 Feb 5. doi: 10.1038/s41401-025-01476-z.
7
The SGLT2 inhibitor empagliflozin exerts neuroprotective effect against hydrogen peroxide-induced toxicity on primary neurons.钠-葡萄糖协同转运蛋白 2 抑制剂恩格列净可发挥神经保护作用,对抗原代神经元过氧化氢诱导的毒性。
Metab Brain Dis. 2024 Nov 19;40(1):15. doi: 10.1007/s11011-024-01478-6.
8
The Role of Programmed Types of Cell Death in Pathogenesis of Heart Failure with Preserved Ejection Fraction.程序性细胞死亡在射血分数保留心力衰竭发病机制中的作用。
Int J Mol Sci. 2024 Sep 14;25(18):9921. doi: 10.3390/ijms25189921.
9
SGLT2 inhibitor downregulated oxidative stress via activating AMPK pathway for cardiorenal (CR) protection in CR syndrome rodent fed with high protein diet.SGLT2 抑制剂通过激活 AMPK 通路下调氧化应激,从而在高蛋白饮食喂养的 CR 综合征啮齿动物中发挥心脏肾脏(CR)保护作用。
J Mol Histol. 2024 Oct;55(5):803-823. doi: 10.1007/s10735-024-10233-1. Epub 2024 Aug 27.
10
The Cardioprotective and Anticancer Effects of SGLT2 Inhibitors: State-of-the-Art Review.钠-葡萄糖协同转运蛋白2抑制剂的心脏保护和抗癌作用:最新综述
JACC CardioOncol. 2024 Mar 12;6(2):159-182. doi: 10.1016/j.jaccao.2024.01.007. eCollection 2024 Apr.